Hygeia Therpaeutics, Inc.

 

Hygeia Therapeutics acquires and develops biodegradable hormone-receptor modulators for topical indications.

Our drug candidates were designed to be rapidly deactivated by enzymes at or near the site of application after the therapeutic purpose is achieved.

By avoiding active or toxic metabolites, Hygeia's topical drug products are expected to have negligible systemic effects and would be safer to use than other drugs in their therapeuctic class.

 

For more information, contact us at info@hygeiatherapeutics.com
Copyright ©2010 Hygeia Therapeutics, Inc. All Rights Reserved.